Solicitation of Nominations for Membership on the Secretary's Advisory Committee on Human Research Protections, 78091-78092 [2014-30400]

Download as PDF Federal Register / Vol. 79, No. 248 / Monday, December 29, 2014 / Notices OMB Number: 3064–0115. Affected Public: Insured financial institutions. Estimated Burden Hours: Number of reports submitted: 50. Hours to prepare the report: 4 hours. Total annual burden hours 200 hours. General Description of Collection: The Prompt Corrective Action (‘‘PCA’’) provisions of section 38 of the Federal Deposit Insurance Act require or permit the FDIC and other federal banking agencies to take certain supervisory actions when FDIC-insured institutions fall within one of five capital categories. They also restrict or prohibit certain activities and require the submission of a capital restoration plan when an insured institution becomes undercapitalized. Various provisions of the statute and the FDIC’s implementing regulations require the prior approval of the FDIC before an FDIC-supervised institution can engage in certain activities, or allow the FDIC to make exceptions to restrictions that would otherwise be imposed. This collection of information consists of the applications that are required to obtain the FDIC’s prior approval. Request for Comment Comments are invited on: (a) Whether the collections of information are necessary for the proper performance of the FDIC’s functions, including whether the information has practical utility; (b) the accuracy of the estimates of the burden of the information collections, including the validity of the methodology and assumptions used; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the information collections on respondents, including through the use of automated collection techniques or other forms of information technology. All comments will become a matter of public record. Dated at Washington, DC, this 22nd day of December, 2014. Federal Deposit Insurance Corporation. Robert E. Feldman, Executive Secretary. [FR Doc. 2014–30333 Filed 12–24–14; 8:45 am] BILLING CODE 6714–01–P tkelley on DSK3SPTVN1PROD with NOTICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Solicitation of Nominations for Membership on the Secretary’s Advisory Committee on Human Research Protections Office for Human Research Protections, Office of the Assistant AGENCY: VerDate Sep<11>2014 19:59 Dec 24, 2014 Jkt 235001 Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AUTHORITY: 42 U.S.C. 217a, section 222 of the Public Health Service Act, as amended. The Committee is governed by the provisions of Public Law 92–463, as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory committees. The Office for Human Research Protections (OHRP), a program office in the Office of the Assistant Secretary for Health, Department of Health and Human Services (HHS), is seeking nominations of qualified candidates to be considered for appointment as members of the Secretary’s Advisory Committee on Human Research Protections (SACHRP). SACHRP provides advice and recommendations to the Secretary, HHS, through the Assistant Secretary for Health on matters pertaining to the continuance and improvement of functions within the authority of HHS directed toward protections for human subjects in research. SACHRP was established by the Secretary, HHS, on October 1, 2002. OHRP is seeking nominations of qualified candidates to fill two positions on the Committee membership that will be vacated during the 2015 calendar year. Previous nominees may be considered for the upcoming vacancies. DATES: Nominations for membership on the Committee must be received no later than February 12, 2015. ADDRESSES: Nominations should be mailed or delivered to Julia Gorey, Executive Director, SACHRP, Office for Human Research Protections, Department of Health and Human Services, 1101 Wootton Parkway, Suite 200; Rockville, MD 20852. Nominations will not be accepted by email or by facsimile. FOR FURTHER INFORMATION CONTACT: Julia Gorey, Executive Director, SACHRP, Office for Human Research Protections, 1101 Wootton Parkway, Suite 200, Rockville, MD 20852, telephone: (240) 453–8141. A copy of the Committee charter and list of the current members can be obtained by contacting Ms. Gorey, accessing the SACHRP Web site at www.hhs.gov/ohrp/sachrp, or requesting via email at sachrp@ osophs.dhhs.gov. SUPPLEMENTARY INFORMATION: The Committee provides advice on matters pertaining to the continuance and improvement of functions within the authority of HHS directed toward protections for human subjects in SUMMARY: PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 78091 research. Specifically, the Committee provides advice relating to the responsible conduct of research involving human subjects with particular emphasis on special populations such as neonates and children, prisoners, the decisionally impaired, pregnant women, embryos and fetuses, individuals and populations in international studies, populations in which there are individually identifiable samples, data or information; and investigator conflicts of interest. In addition, the Committee is responsible for reviewing selected ongoing work and planned activities of the OHRP and other offices/agencies within HHS responsible for human subjects protection. These evaluations may include, but are not limited to, a review of assurance systems, the application of minimal research risk standards, the granting of waivers, education programs sponsored by OHRP, and the ongoing monitoring and oversight of institutional review boards (IRBs) and the institutions that sponsor research. Nominations: The OHRP is requesting nominations to fill two positions for voting members of SACHRP which will become vacant in July 2015. Nominations of potential candidates for consideration are being sought from a wide array of fields, including, but not limited to: Public health and medicine, behavioral and social sciences, health administration, and biomedical ethics. To qualify for consideration of appointment to the Committee, an individual must possess demonstrated experience and expertise in any of the several disciplines and fields pertinent to human subjects protection and/or clinical research. The individuals selected for appointment to the Committee can be invited to serve a term of up to four years. Committee members receive a stipend and reimbursement for per diem and any travel expenses incurred for attending Committee meetings and/or conducting other business in the interest of the Committee. Interested applicants may self-nominate. Nominations may be retained and considered for future vacancies. Nominations should be typewritten. The following information should be included in the package of material submitted for each individual being nominated for consideration: (1) A letter of nomination that clearly states the name and affiliation of the nominee, the basis for the nomination (i.e., specific attributes which qualify the nominee for service in this capacity), and a statement that the nominee is willing to serve as E:\FR\FM\29DEN1.SGM 29DEN1 78092 Federal Register / Vol. 79, No. 248 / Monday, December 29, 2014 / Notices a member of the Committee; (2) the nominator’s name, address, daytime telephone number, and the home and/ or work address, telephone number, and email address of the individual being nominated; and (3) a current copy of the nominee’s curriculum vitae. Federal employees should not be nominated for consideration of appointment to this Committee. The Department makes every effort to ensure that the membership of HHS Federal advisory committees is fairly balanced in terms of points of view represented and the committee’s function. Every effort is made to ensure that individuals from a broad representation of geographic areas, women and men, ethnic and minority groups, and the disabled are given consideration for membership on HHS Federal advisory committees. Appointment to this Committee shall be made without discrimination on the basis of age, race, ethnicity, gender, sexual orientation, disability, and cultural, religious, or socioeconomic status. Individuals who are selected to be considered for appointment will be required to provide detailed information regarding their financial holdings, consultancies, and research grants or contracts. Disclosure of this information is necessary in order to determine if the selected candidate is involved in any activity that may pose a potential conflict with the official duties to be performed as a member of SACHRP. Dated: December 22, 2014. Jerry Menikoff, Director, Office for Human Research Protections, Executive Secretary, Secretary’s Advisory Committee, on Human Research Protections. [FR Doc. 2014–30400 Filed 12–24–14; 8:45 am] Report to Congress is required to be submitted no later than June 30, 2015, under title III, section 305 of H.R. 4980 (Pub. L. 113–183), Preventing Sex Trafficking and Strengthening Families Act of 2014. ACF stated in the notice that the request for information would remain open until December 22, 2014, for the receipt of public comments. To provide the public with more time to comment, ACF extends the period of time for which the comments will remain open. To provide clarification on the first bullet point under the Background Section, which was truncated in the first Federal Register Notice, please consider the following: A review of the effectiveness of state child support programs and collection practices and an analysis of the extent to which the practices result in unintended consequences or performance issues. DATES: Comments must be received by 11:59 p.m. on February 27, 2015, to be considered. FOR FURTHER INFORMATION CONTACT: The Office of Child Support Enforcement at OCSEreport@acf.hhs.gov. Dated: December 19, 2014. Donna Bonar, Deputy Comissioner, Office of Child Support Enforcement. [FR Doc. 2014–30285 Filed 12–24–14; 8:45 am] BILLING CODE 4184–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2014–N–2214] Next Generation Sequencing Diagnostic Tests; Public Workshop; Request for Comments BILLING CODE 4150–36–P AGENCY: Food and Drug Administration, HHS. DEPARTMENT OF HEALTH AND HUMAN SERVICES ACTION: Administration for Children and Families SUMMARY: Notice of public workshop; request for comments. Request for Information Office of Child Support Enforcement (OCSE), Administration for Children and Families, HHS. ACTION: Notice of request for information. tkelley on DSK3SPTVN1PROD with NOTICES AGENCY: The Administration for Children and Families (ACF) published a notice in the Federal Register on October 23, 2014, (79 FR 63406) requesting public comments to inform its upcoming Report to Congress. The SUMMARY: VerDate Sep<11>2014 19:09 Dec 24, 2014 Jkt 235001 The Food and Drug Administration (FDA) is announcing the following public workshop entitled ‘‘Optimizing FDA’s Regulatory Oversight of Next Generation Sequencing Diagnostic Tests.’’ The purpose of this workshop is to discuss and receive feedback from the community on the questions in the discussion paper on diagnostic tests for human genetics or genomics using next generation sequencing (NGS) technology. DATES: The public workshop will be held on February 20, 2015, from 8:30 a.m. to 5 p.m. PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 The public workshop will be held at the Natcher Center at the National Institutes of Health Campus, 9000 Rockville Pike, Bldg. 45 Auditorium, Bethesda, MD 20814. For parking and security information, please refer to http://www.nih.gov/about/ visitor/. FOR FURTHER INFORMATION CONTACT: David Litwack, Office of In Vitro Diagnostics and Radiological Health, Center for Devices and Radiological Health, Food and Drug Administration, Bldg. 66, Rm. 5544, 10903 New Hampshire Ave., Silver Spring, MD 20993, 301–796–6697, email: ernest.litwack@fda.hhs.gov. SUPPLEMENTARY INFORMATION: Registration: Registration is free and available on a first-come, first-served basis. Persons interested in attending this public workshop must register online by 4 p.m. February 12, 2015. Early registration is recommended because facilities are limited and, therefore, FDA may limit the number of participants from each organization. If time and space permits, onsite registration on the day of the public workshop will be provided beginning at 7:30 a.m. If you need special accommodations due to a disability, please contact Susan Monahan, 301–796–5661, email: Susan.Monahan@fda.hhs.gov no later than February 6, 2015. To register for the public workshop, please visit FDA’s Medical Devices News & Events—Workshops & Conferences calendar at http:// www.fda.gov/MedicalDevices/ NewsEvents/WorkshopsConferences/ default.htm. (Select this public workshop from the posted events list.) Please provide complete contact information for each attendee, including name, title, affiliation, address, email, and telephone number. If you are unable to register online, please contact Susan Monahan (see Registration.) Registrants will receive confirmation after they have been accepted. You will be notified if you are on a waiting list. Streaming Webcast of the Public Workshop: This public workshop will also be Webcast. Persons interested in viewing the Webcast must register online by February 12, 2015. Early registration is recommended because Webcast connections are limited. Organizations are requested to register all participants, but to view using one connection per location. Webcast participants will be sent technical system requirements after registration and will be sent connection access information after February 13, 2015. If you have never attended a Connect Pro ADDRESSES: E:\FR\FM\29DEN1.SGM 29DEN1

Agencies

[Federal Register Volume 79, Number 248 (Monday, December 29, 2014)]
[Notices]
[Pages 78091-78092]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-30400]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Solicitation of Nominations for Membership on the Secretary's 
Advisory Committee on Human Research Protections

AGENCY: Office for Human Research Protections, Office of the Assistant 
Secretary for Health, Office of the Secretary, Department of Health and 
Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

    AUTHORITY: 42 U.S.C. 217a, section 222 of the Public Health 
Service Act, as amended. The Committee is governed by the provisions 
of Public Law 92-463, as amended (5 U.S.C. Appendix 2), which sets 
forth standards for the formation and use of advisory committees.
SUMMARY: The Office for Human Research Protections (OHRP), a program 
office in the Office of the Assistant Secretary for Health, Department 
of Health and Human Services (HHS), is seeking nominations of qualified 
candidates to be considered for appointment as members of the 
Secretary's Advisory Committee on Human Research Protections (SACHRP). 
SACHRP provides advice and recommendations to the Secretary, HHS, 
through the Assistant Secretary for Health on matters pertaining to the 
continuance and improvement of functions within the authority of HHS 
directed toward protections for human subjects in research. SACHRP was 
established by the Secretary, HHS, on October 1, 2002. OHRP is seeking 
nominations of qualified candidates to fill two positions on the 
Committee membership that will be vacated during the 2015 calendar 
year. Previous nominees may be considered for the upcoming vacancies.

DATES: Nominations for membership on the Committee must be received no 
later than February 12, 2015.

ADDRESSES: Nominations should be mailed or delivered to Julia Gorey, 
Executive Director, SACHRP, Office for Human Research Protections, 
Department of Health and Human Services, 1101 Wootton Parkway, Suite 
200; Rockville, MD 20852. Nominations will not be accepted by email or 
by facsimile.

FOR FURTHER INFORMATION CONTACT: Julia Gorey, Executive Director, 
SACHRP, Office for Human Research Protections, 1101 Wootton Parkway, 
Suite 200, Rockville, MD 20852, telephone: (240) 453-8141. A copy of 
the Committee charter and list of the current members can be obtained 
by contacting Ms. Gorey, accessing the SACHRP Web site at www.hhs.gov/ohrp/sachrp, or requesting via email at sachrp@osophs.dhhs.gov.

SUPPLEMENTARY INFORMATION: The Committee provides advice on matters 
pertaining to the continuance and improvement of functions within the 
authority of HHS directed toward protections for human subjects in 
research. Specifically, the Committee provides advice relating to the 
responsible conduct of research involving human subjects with 
particular emphasis on special populations such as neonates and 
children, prisoners, the decisionally impaired, pregnant women, embryos 
and fetuses, individuals and populations in international studies, 
populations in which there are individually identifiable samples, data 
or information; and investigator conflicts of interest.
    In addition, the Committee is responsible for reviewing selected 
ongoing work and planned activities of the OHRP and other offices/
agencies within HHS responsible for human subjects protection. These 
evaluations may include, but are not limited to, a review of assurance 
systems, the application of minimal research risk standards, the 
granting of waivers, education programs sponsored by OHRP, and the 
ongoing monitoring and oversight of institutional review boards (IRBs) 
and the institutions that sponsor research.
    Nominations: The OHRP is requesting nominations to fill two 
positions for voting members of SACHRP which will become vacant in July 
2015. Nominations of potential candidates for consideration are being 
sought from a wide array of fields, including, but not limited to: 
Public health and medicine, behavioral and social sciences, health 
administration, and biomedical ethics. To qualify for consideration of 
appointment to the Committee, an individual must possess demonstrated 
experience and expertise in any of the several disciplines and fields 
pertinent to human subjects protection and/or clinical research.
    The individuals selected for appointment to the Committee can be 
invited to serve a term of up to four years. Committee members receive 
a stipend and reimbursement for per diem and any travel expenses 
incurred for attending Committee meetings and/or conducting other 
business in the interest of the Committee. Interested applicants may 
self-nominate. Nominations may be retained and considered for future 
vacancies.
    Nominations should be typewritten. The following information should 
be included in the package of material submitted for each individual 
being nominated for consideration: (1) A letter of nomination that 
clearly states the name and affiliation of the nominee, the basis for 
the nomination (i.e., specific attributes which qualify the nominee for 
service in this capacity), and a statement that the nominee is willing 
to serve as

[[Page 78092]]

a member of the Committee; (2) the nominator's name, address, daytime 
telephone number, and the home and/or work address, telephone number, 
and email address of the individual being nominated; and (3) a current 
copy of the nominee's curriculum vitae. Federal employees should not be 
nominated for consideration of appointment to this Committee.
    The Department makes every effort to ensure that the membership of 
HHS Federal advisory committees is fairly balanced in terms of points 
of view represented and the committee's function. Every effort is made 
to ensure that individuals from a broad representation of geographic 
areas, women and men, ethnic and minority groups, and the disabled are 
given consideration for membership on HHS Federal advisory committees. 
Appointment to this Committee shall be made without discrimination on 
the basis of age, race, ethnicity, gender, sexual orientation, 
disability, and cultural, religious, or socioeconomic status.
    Individuals who are selected to be considered for appointment will 
be required to provide detailed information regarding their financial 
holdings, consultancies, and research grants or contracts. Disclosure 
of this information is necessary in order to determine if the selected 
candidate is involved in any activity that may pose a potential 
conflict with the official duties to be performed as a member of 
SACHRP.

    Dated: December 22, 2014.
Jerry Menikoff,
Director, Office for Human Research Protections, Executive Secretary, 
Secretary's Advisory Committee, on Human Research Protections.
[FR Doc. 2014-30400 Filed 12-24-14; 8:45 am]
BILLING CODE 4150-36-P